Comprehensive and Rapid Genotyping of Mutations and Haplotypes in Congenital Bilateral Absence of the Vas Deferens and Other Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders

Audrézet, 2004, Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms, Hum Mutat, 23, 343, 10.1002/humu.20009 Niel, 2004, Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis, J Med Genet, 41, e118, 10.1136/jmg.2004.022400 Bombieri, 2005, Frequency of large CFTR gene rearrangements in Italian CF patients, Eur J Hum Genet, 13, 687, 10.1038/sj.ejhg.5201387 Hantash, 2006, Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening, Hum Genet, 119, 126, 10.1007/s00439-005-0082-0 Hantash, 2006, A large deletion in the CFTR gene in CBAVD, Genet Med, 8, 93, 10.1097/01.gim.0000200945.54234.d7 Niel, 2006, A new large CFTR rearrangement illustrates the importance of searching for complex alleles, Hum Mutat, 27, 716, 10.1002/humu.9431 Ratbi, 2007, Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling, Hum Reprod, 22, 1285, 10.1093/humrep/dem024 Claustres, 2000, Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France, Hum Mutat, 16, 143, 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J Claustres, 2005, Molecular pathology of the CFTR locus in male infertility, Reprod Biomed Online, 10, 14, 10.1016/S1472-6483(10)60801-2 Buratti, 2001, Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9, J Biol Chem, 276, 36337, 10.1074/jbc.M104236200 Viel, 2005, Novel length variant of the polypyrimidine tract within the splice acceptor site in intron 8 of the CFTR gene: consequences for genetic testing using standard assays, Eur J Hum Genet, 13, 136, 10.1038/sj.ejhg.5201261 Millson, 2005, Direct molecular haplotyping of the IVS-8 poly(TG) and polyT repeat tracts in the cystic fibrosis gene by melting curve analysis of hybridization probes, Clin Chem, 51, 1619, 10.1373/clinchem.2005.052159 Kobler, 2006, Identification of an 11T allele in the polypyrimidine tract of intron 8 of the CFTR gene, Genet Med, 8, 125, 10.1097/01.gim.0000200217.85820.47 Cuppens, 1998, Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes: the polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation, J Clin Invest, 101, 487, 10.1172/JCI639 Disset, 2005, A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with congenital bilateral absence of vas deferens (CBAVD), Hum Mutat, 25, 72, 10.1002/humu.20115 Groman, 2004, Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign, Am J Hum Genet, 74, 176, 10.1086/381001 Taulan, 2007, Large genomic rearrangements in the CFTR gene contribute to CBAVD, BMC Med Genet, 8, 22, 10.1186/1471-2350-8-22 Zielenski, 1991, Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, Genomics, 10, 214, 10.1016/0888-7543(91)90503-7 Fanen, 1992, Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions, Genomics, 13, 770, 10.1016/0888-7543(92)90152-I Chillón, 1995, Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens, N Engl J Med, 332, 1475, 10.1056/NEJM199506013322204 Chillón, 1995, A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA→G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype, Am J Hum Genet, 56, 623 Highsmith, 1994, A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations, N Engl J Med, 331, 974, 10.1056/NEJM199410133311503 Dörk, 1997, Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens, Hum Genet, 100, 365, 10.1007/s004390050518 Don, 1991, ‘Touchdown’ PCR to circumvent spurious priming during gene amplification, Nucleic Acids Res, 19, 4008, 10.1093/nar/19.14.4008 Strom, 2003, Extensive sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test, Genet Med, 5, 9, 10.1097/00125817-200301000-00002 Lucarelli, 2006, A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene, Anal Biochem, 353, 226, 10.1016/j.ab.2006.03.022 McGinniss, 2005, Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples, Hum Genet, 118, 331, 10.1007/s00439-005-0065-1 Baux, 2007, Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients, Hum Mutat, 28, 781, 10.1002/humu.20513 Roux, 2006, Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%, J Med Genet, 43, 763, 10.1136/jmg.2006.041954 Lucarelli, 2002, Simultaneous cycle sequencing assessment of (TG)m and Tn tract length in CFTR gene, Biotechniques, 32, 540, 10.2144/02323st06 Costa, 2006, Simultaneous molecular haplotyping of both IVS8 (TG)m and (T)n tracts in the CFTR gene: still a challenge, Clin Chem, 52, 1621, 10.1373/clinchem.2005.065383